Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolamine vs propofol for perioperative cognition and mood in depressed patients
ChiCTR2000034899Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, Jingzhou First People's Hospital
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propofol in major depressive disorder (MDD), perioperative neurocognitive disorder and anxiety disorder (3 arms), sponsored by Department of Anesthesiology, Jingzhou First People's Hospital. Primary endpoints: Mini-Mental State Examination score, Self-Rating Depression Scale score and 1 more. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
propofol
03
Conditions
major depressive disorder (MDD)perioperative neurocognitive disorderanxiety disorder
Beyond the preview
Go deeper on ChiCTR2000034899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034899.